ZOTH LOTA S

Director at enGene Therapeutics Inc. · on record since Dec 19, 2023
Director at Orexigen Therapeutics, Inc. · on record since Apr 30, 2012
Director at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
Director at FIRST FINANCIAL BANKSHARES INC · on record since May 5, 2026
Director at LUMOS PHARMA, INC. · on record since Nov 6, 2012
Director at INOVIO PHARMACEUTICALS, INC. · on record since May 21, 2026
Director at Spark Therapeutics, Inc. · on record since Jan 8, 2016
SVP & Chief Financial Officer at MEDIMMUNE INC /DE · on record since Feb 18, 2005
Director at Zymeworks BC Inc. · on record since Jan 2, 2019
Director at 89bio, Inc. · on record since Jun 16, 2020
CHIEF SCIENTIFIC OFFICER at Spark Therapeutics, Inc. · on record since Dec 17, 2019

Insider trading activity of ZOTH LOTA S

Transactions on record: 152; since Mar 10, 2004

Open-market buys: 0

Open-market sells: 7; $84K

Companies traded: 11; last filing Jun 17, 2026

Figures computed from official regulatory filings — .

Companies where ZOTH LOTA S has traded

enGene Therapeutics Inc.4 tx · Jun 17, 2026
INOVIO PHARMACEUTICALS, INC.39 tx · $37.8K · May 21, 2026
FIRST FINANCIAL BANKSHARES INC1 tx · May 5, 2026
89bio, Inc.12 tx · Oct 30, 2025
LUMOS PHARMA, INC.47 tx · Dec 13, 2024
1 tx · Dec 23, 2022
3 tx · May 7, 2021
15 tx · $343.5K · Dec 17, 2019
7 tx · Jul 18, 2017
9 tx · $1.8M · May 8, 2015
14 tx · $46.2K · Jun 19, 2007

Track record of ZOTH LOTA S

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ZOTH LOTA S

Co-insiders of ZOTH LOTA S

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
enGene Therapeutics Inc.Listing on record	Jun 17, 2026	AwardD (derivative)	31,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2026	AwardD (derivative)	34,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2026	AwardD (derivative)	41,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIRST FINANCIAL BANKSHARES INCListing on record	May 5, 2026	Award	2,142	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-27,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-45,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-56,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
enGene Therapeutics Inc.Listing on record	Jun 16, 2025	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2025	ExerciseD (derivative)	-2,167	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2025	Exercise	2,167	—	n/a (No price was disclosed in the filing)	SEC
89bio, Inc.Listing unverified	Feb 5, 2025	AwardD (derivative)	56,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-2,910	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-2,777	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-5,324	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-3,345	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-3,328	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	Other	-2,187	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-5,684	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-3,431	—	n/a (No price was disclosed in the filing)	SEC
enGene Therapeutics Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
LUMOS PHARMA, INC.Listing unverified	Jun 7, 2024	AwardD (derivative)	3,328	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 22, 2024	AwardD (derivative)	2,167	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
enGene Therapeutics Inc.Listing on record	Jun 17, 2026	AwardD (derivative)	31,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2026	AwardD (derivative)	34,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2026	AwardD (derivative)	41,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIRST FINANCIAL BANKSHARES INCListing on record	May 5, 2026	Award	2,142	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-27,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-45,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
89bio, Inc.Listing unverified	Oct 30, 2025	OtherD (derivative)	-56,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
enGene Therapeutics Inc.Listing on record	Jun 16, 2025	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2025	ExerciseD (derivative)	-2,167	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 21, 2025	Exercise	2,167	—	n/a (No price was disclosed in the filing)	SEC
89bio, Inc.Listing unverified	Feb 5, 2025	AwardD (derivative)	56,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-2,910	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-2,777	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-5,324	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-3,345	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-3,328	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	Other	-2,187	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-5,684	—	n/a (No price was disclosed in the filing)	SEC
LUMOS PHARMA, INC.Listing unverified	Dec 13, 2024	OtherD (derivative)	-3,431	—	n/a (No price was disclosed in the filing)	SEC
enGene Therapeutics Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
LUMOS PHARMA, INC.Listing unverified	Jun 7, 2024	AwardD (derivative)	3,328	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INOVIO PHARMACEUTICALS, INC.Listing on record	May 22, 2024	AwardD (derivative)	2,167	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC